Astellas Pharma Inc. (ALPMF) This autumn 2024 Earnings Name Transcript

Astellas Pharma Inc. (OTCPK:ALPMF) This autumn 2024 Earnings Convention Name April 25, 2025 4:00 AM ET

Firm Individuals

Hiromitsu Ikeda – Chief Communications and IR Officer
Naoki Okamura – Consultant Director, President & Chief Govt Officer
Claus Zieler – Chief Industrial Officer & Medical Affairs Officer
Tadaaki Taniguchi – Chief Medical Officer
Atsushi Kitamura – Chief Monetary Officer

Convention Name Individuals

Hidemaru Yamaguchi – Citigroup Securities
Seiji Wakao – JPMorgan Securities
Akinori Ueda – Goldman Sachs Securities
Shinichiro Muraoka – Morgan Stanley MUFG Securities
Hiroyuki Matsubara – Nomura Securities
Miki Sogi – Sanford C. Bernstein
Kazuaki Hashiguchi – Daiwa Securities
Fumiyoshi Sakai – UBS Securities

Hiromitsu Ikeda

Thanks very a lot for becoming a member of our FY 2024 Monetary Outcomes Announcement Assembly by Astellas Pharma Inc. out of your very busy schedule immediately. I am delighted to function a moderator. I am Ikeda, Chief Communications and IR Officer. Thanks to your time.

In the present day after presentation, we transfer on to Q&A session. Presentation will probably be made based mostly on the fabric posted on our web site beneath the IR Assembly Part. We’ve got simultaneous translation between Japanese and English together with Q&A. We can’t assure the accuracy of the interpretation. Thanks for understanding. You possibly can select the language from the menu on the Zoom webinar display. If you choose the unique language, you may take heed to the unique sound with out going by the interpretation.

Disclaimer for immediately, this materials or illustration by representatives for the corporate, and their solutions and assertion within the Q&A session contains forward-looking statements based mostly on assumptions and beliefs in mild of the data at the moment accessible to administration and topic to important dangers and uncertainties. Precise monetary outcomes could differ materially relying on quite a few elements. They comprise info on prescription drugs, together with compounds beneath improvement, however this info shouldn’t be supposed to make any representations or ads